HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

OPEN ACCESS ARTICLE

This Article Free via Open Access: OA OA Full Text Full Text (PDF) OA All Versions of this Article: 2008-0030v1 26/10/2682    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Amos, P. J. Articles by Peirce, S. M. Search for Related Content PubMed PubMed Citation Articles by Amos, P. J. Articles by Peirce, S. M.

INTRODUCTION: IFATS COLLECTION: TISSUE-SPECIFIC STEM CELLS

IFATS Collection: The Role of Human Adipose-Derived Stromal Cells in Inflammatory Microvascular Remodeling and Evidence of a Perivascular Phenotype

^aDepartment of Biomedical Engineering and
^bDepartment of Plastic Surgery, University of Virginia, Charlottesville, Virginia, USA

Key Words. Adipose-derived stromal cells • Microcirculation • Pericyte • Angiogenesis

Correspondence: Correspondence: Shayn M. Peirce, Ph.D.,Dept. of Biomedical Engineering, University of Virginia, P.O. Box 800759, 415 Lane Rd., Charlottesville, VA 22908, USA. Telephone: 434-243-5795; Fax: 434-982-3870; e-mail: speirce{at}virginia.edu

Received on January 11, 2008; accepted for publication on April 7, 2008.

First published online in STEM CELLS EXPRESS  April 24, 2008.

A growing body of literature suggests that human adipose-derived stromal cells (hASCs) possess developmental plasticity both in vitro and in vivo, and might represent a viable cell source for therapeutic angiogenesis and tissue engineering. We investigate their phenotypic similarity to perivascular cell types, ability to contribute to in vivo microvascular remodeling, and ability to modulate vascular stability. We evaluated hASC surface expression of vascular and stem/progenitor cell markers in vitro, as well as any effects of platelet-derived growth factor B chain (PDGF-BB) and vascular endothelial growth factor 165 on in vitro hASC migration. To ascertain in vivo behavior of hASCs in an angiogenic environment, hASCs were isolated, expanded in culture, labeled with a fluorescent marker, and injected into adult nude rat mesenteries that were stimulated to undergo microvascular remodeling. Ten, 30, and 60 days after injection, tissues from anesthetized animals were harvested and processed with immunohistochemical techniques to determine hASC quantity, positional fate in relation to microvessels, and expression of endothelial and perivascular cell markers. After 60 days, 29% of hASCs exhibited perivascular morphologies compared with 11% of injected human lung fibroblasts. hASCs exhibiting perivascular morphologies also expressed markers characteristic of vascular pericytes: smooth muscle -actin (10%) and neuron-glia antigen 2 (8%). In tissues treated with hASCs, vascular density was significantly increased over age-matched controls lacking hASCs. This study demonstrates that hASCs express pericyte lineage markers in vivo and in vitro, exhibit increased migration in response to PDGF-BB in vitro, exhibit perivascular morphology when injected in vivo, and contribute to increases in microvascular density during angiogenesis by migrating toward vessels.

Disclosure of potential conflicts of interest is found at the end of this article.